Singh, Shilpa
Gleason, Catherine E. https://orcid.org/0000-0002-0063-0729
Fang, Min
Laimon, Yasmin N. https://orcid.org/0000-0003-0848-9843
Khivansara, Vishal
Xie, Shanhai
Durmaz, Yavuz T.
Sarkar, Aniruddha https://orcid.org/0000-0002-9393-1335
Ngo, Kenneth
Savla, Varunika
Li, Yixiang
Abu-Remaileh, Muhannad
Li, Xinyue
Locquet, Marie-Anais
Tuladhar, Bishma
Odeh, Ranya
Hamkins-Indik, Frances
He, Daphne
Membreno, Miles W.
Nosrati, Meisam
Gushwa, Nathan N.
Leung, Siegfried S. F.
Fraga-Walton, Breena
Hernandez, Luis
Baldomero, Miguel P.
Lent, Bryan M.
Spellmeyer, David https://orcid.org/0009-0002-9259-0767
Luna, Joshua F.
Hoang, Dalena
Gritsenko, Yuliana
Chand, Manesh
DeMart, Megan K.
Metobo, Sammy
Bhatt, Chinmay
Shapiro, Justin A.
Yang, Kai
Dupper, Nathan J.
Bockus, Andrew T. https://orcid.org/0000-0001-5522-6523
Fang, Jinshu
Bambal, Ramesh
Cremin, Peadar
Doench, John G. https://orcid.org/0000-0002-3707-9889
Aggen, James B.
Liu, Li-Fen
Levin, Bernard
Wang, Evelyn W.
Vendrell, Iolanda
Fischer, Roman https://orcid.org/0000-0002-9715-5951
Kessler, Benedikt https://orcid.org/0000-0002-8160-2446
Gokhale, Prafulla C. https://orcid.org/0000-0002-1974-5921
Signoretti, Sabina https://orcid.org/0000-0002-5000-9105
Spektor, Alexander https://orcid.org/0000-0002-1085-3205
Kreatsoulas, Constantine
Evangelista, Marie
Singh, Rajinder
Earp, David J.
Nijhawan, Deepak
Garcia, Pablo D.
Oser, Matthew G. https://orcid.org/0000-0003-2047-0969
Article History
Received: 30 July 2024
Accepted: 18 July 2025
First Online: 20 August 2025
Competing interests
: M.G.O. reports grants from Eli Lilly, Takeda, Novartis, BMS, Auron Therapeutics and Circle Pharma. M.G.O. and D.N. received an SRA from Circle Pharma to fund this work. C.E.G., R.O., F.H.-I., D. He, M.W.M., M.N., N.N.G., S.S.F.L., B.F.-W., L.H., M.P.B., B.M.L., D.S., J.F.L., D. Hoang, Y.G., M.C., M.K.D., S.M., C.B., J.A.S., K.Y., N.J.D., A.T.B., J.F., R.B., P.C., J.B.A., L.-F.L., B.L., E.W.W., C.K., M.E., R.S., D.J.E. and P.D.G. are employees of Circle Pharma. The other authors declare no competing interests.